SEC Filing: Form 10-K
Annual report [Section 13 and 15(d), not S-K Item 405]
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Annual report [Section 13 and 15(d), not S-K Item 405]
Prospectuses and communications, business combinations
Current report
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities